Abstract:Active surveillance, as a first-line treatment strategy for low-risk papillary thyroid microcarcinoma, has been recommended by guidelines worldwide. However, active surveillance has not been widely accepted by doctors and patients in China. In view of the huge challenges faced by active surveillance, doctors should improve their understanding of the "low risk" of papillary thyroid micropapillary cancer, identify some intermediate or high-risk cases, be familiar with the criteria and methods of diagnosis for disease progression, and timely turn patients with disease progression into more active treatment strategies. By analyzing the long-term cost-effectiveness of active surveillance, it is clear that medical expense is only one cost form of medical activities, and the health cost (thyroid removal and surgical complications) paid by patients due to"over-diagnosis and over-treatment" is the most important. Moreover, the weakening of the patients' social function caused by surgical procedures is a more hidden and far-reaching cost. The formulation of health economic policies (including medical insurance) should promote the adjustment of diagnosis and treatment behavior to the direction which is conducive to the long-term life and treatment of patients, improving the overall health level of society and reducing the overall cost. At the same time, doctors should stimulate the subjective initiative of patients, help them fully understand the impact of various treatment methods on their psychological and physical status, support patients psychologically, and strengthen their confidence in implementing active surveillance. By strengthening multi-disciplinary treatment team and system support, doctors can achieve risk stratification of papillary thyroid microcarcinoma, accurate judgment of disease progress, timely counseling for psychological problems, and long-term adherence to active surveillance. Improving the treatment level of advanced thyroid cancer is the key point of improve the prognosis. It is important to promote the development of active surveillance for low-risk papillary thyroid microcarcinoma. In the future, it is necessary to carry out multi-center prospective research and accumulate research evidence for promoting the standardization process of active surveillance. Standardized active surveillance will certainly benefit specific papillary thyroid microcarcinoma patients.

Progress in active surveillance for adult low-risk papillary thyroid microcarcinoma

Active Surveillance As a Management Strategy for Papillary Thyroid Microcarcinoma

Active Surveillance of Low-Risk Papillary Thyroid Carcinoma: a Promising Strategy Requiring Additional Evidence.

Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects

Evaluation of Clinical Risk Factors for Predicting Insidious Right Central and Posterior Right Recurrent Laryngeal Nerve Lymph Node Metastasis in Papillary Thyroid Microcarcinoma Patients (cn0): Experience of a Single Center.

The Efficacy and the Safety of Ultrasound-guided Ablation Therapy for Treating Papillary Thyroid Microcarcinoma.

Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review

Choosing Optimal Microcarcinoma Patients for Active Surveillance Study (Compass): Effectiveness Evaluation of a Preoperative Clinical Framework

Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines

Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery?

[Discussion on how to optimize active surveillance for low-risk papillary thyroid microcarcinoma in China]

Tumor growth manifested in two-fifths of low-risk papillary thyroid microcarcinoma patients during active surveillance: data from a tertiary center in China

Predictive features of central lymph node metastasis in papillary thyroid microcarcinoma: Roles of active surveillance in over-treatment

Active surveillance vs. surgery in low‐risk papillary thyroid microcarcinoma patients and the risk of loss to follow‐up

Outcomes and effectiveness of active surveillance for low-risk papillary thyroid carcinoma: a systematic review and meta-analysis

The safety and efficacy of delayed surgery by simulating clinical progression of observable papillary thyroid microcarcinoma: a retrospective analysis of 524 patients from a single medical center

Contrastive Study of Two Screening Criteria for Active Surveillance in Patients with Low-Risk Papillary Thyroid Microcarcinoma: A Retrospective Analysis of 1001 Patients

[Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].

Long‐term outcomes of active surveillance for low‐risk papillary thyroid carcinoma: Progression patterns and tumor calcification

US-guided Microwave Ablation of Low-Risk Papillary Thyroid Microcarcinoma: Longer-Term Results of a Prospective Study

Feasibility of Active Surveillance in Patients with Clinically T1b Papillary Thyroid Carcinoma ≤1.5 cm in Preoperative Ultrasonography: MASTER Study